Zonisamide and Methylprednisolone to Prevent Noise-induced Temporary Hearing Loss
Not yet recruiting
Phase of Trial: Phase I/II
Latest Information Update: 15 Dec 2015
At a glance
- Drugs Methylprednisolone (Primary) ; Zonisamide (Primary)
- Indications Noise-induced hearing loss
- Focus Therapeutic Use
- 10 Dec 2015 Planned End Date changed from 1 Jan 2019 to 1 Jan 2020 as reported by ClinicalTrials.gov record.
- 10 Dec 2015 Planned primary completion date changed from 1 Dec 2018 to 1 Dec 2019 as reported by ClinicalTrials.gov record.
- 10 Dec 2015 Planned initiation date changed from 1 Jun 2016 to 1 Jun 2017 as reported by ClinicalTrials.gov record.